SP Scientific Licenses Praxair's ControLyo Nucleation Technology
SP Scientific (Gardiner, NY) has signed a license agreement to use Praxair's (Danbury, CT) ControLyo nucleation-on-demand technology, which provides pharmaceutical and biotechnology companies with control over the freeze-drying process for drug developmental efforts.
SP Scientific (Gardiner, NY) has signed a license agreement to use Praxair's (Danbury, CT) ControLyo nucleation-on-demand technology, which provides pharmaceutical and biotechnology companies with control over the freeze-drying process for drug developmental efforts.
The ControLyo technology was specifically developed to control the freezing step of lyophilization. In traditional lyophilization, the freezing step is uncontrolled because of the random nature of the nucleation or crystal-forming process. The ControLyo technology, however, controls the nucleation temperature to within 1 °C of its freezing point, which improves product uniformity, quality, and yield, and can reduce cycle times by as much as 40%.
Mastering Antibody-Drug Conjugates
December 19th 2024In this episode, we explore BIOVECTRA’s capabilities in antibody-drug conjugate (ADC) manufacturing, from complex conjugation chemistry to synthesis of highly potent payloads. We’ll also showcase how BIOVECTRA’s extensive experience in complex chemistries and specialized small molecule manufacturing gives them a unique perspective, strengthening their approach to ADC production and ensuring clients receive custom solutions across all project stages.
